Peptide Comparison
Matrixyl vs Syn-Coll
Editorial breakdown of mechanism, evidence, decision criteria, and the misconceptions worth calling out.
Data-derived verdict
Matrixyl and Syn-Coll share the cosmetic / collagen-stimulator classes and carry roughly equivalent evidence (Cosmetic Clinical Studies / Cosmetic Clinical Studies). On the catalogued data layer Matrixyl has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; Matrixyl's evidence base is currently denser.
Evidence at a glance
FDA-approved Phase 3 Phase 2 / approved abroad Anecdotal + animal Preclinical / flagged
Shared safety considerations
Both compounds share these reported concerns: minimal. Open each peptide page for the full risk paragraph and source citations.
Side-by-side
| Matrixyl | Syn-Coll | |
|---|---|---|
| Class | Cosmetic signal peptide; collagen stimulator | Cosmetic lipopeptide (collagen) |
| Drug class | Dermatologic | Dermatologic |
| Mechanism | Mimics procollagen I fragment; signals fibroblasts to produce collagen, elastin, GAGs | TSP-1 mimic; activates latent TGF-β; stimulates collagen synthesis |
| Route | Topical | Topical |
| Half-life | Topical | Topical |
| Dosage (research) | Topical 3-10% | Topical 1-5% |
| Evidence tier | Cosmetic Clinical Studies | Cosmetic Clinical Studies |
| Research depth | 32 indexed | 12 indexed |
| Availability | Cosmetic | Cosmetic |
| Reported risks | Minimal (topical) | Minimal |
Reported research data only. "Studied for" and "reported in literature" describe published research focus, not clinical recommendation. Most peptides catalogued here are not FDA-approved for human use.
Frequently asked questions
Should I pick Matrixyl or Syn-Coll?
Matrixyl and Syn-Coll share the cosmetic / collagen-stimulator classes and carry roughly equivalent evidence (Cosmetic Clinical Studies / Cosmetic Clinical Studies). On the catalogued data layer Matrixyl has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; Matrixyl's evidence base is currently denser.
What is the difference between Matrixyl and Syn-Coll?
Matrixyl is classed as Cosmetic signal peptide; collagen stimulator; Syn-Coll is classed as Cosmetic lipopeptide (collagen). Reported mechanism: Matrixyl, Mimics procollagen I fragment; signals fibroblasts to produce collagen, elastin, GAGs; Syn-Coll, TSP-1 mimic; activates latent TGF-β; stimulates collagen synthesis. Reported half-life: Matrixyl, Topical; Syn-Coll, Topical. Routes in published studies: Matrixyl, Topical; Syn-Coll, Topical.
Which has stronger evidence, Matrixyl or Syn-Coll?
Matrixyl and Syn-Coll sit on the same rung of PeptideHelper.org's five-step evidence scale, which runs from preclinical to FDA-approved. Matrixyl is graded Cosmetic Clinical Studies, with 6 cited sources on its reference page and 32 indexed studies. Syn-Coll is graded Cosmetic Clinical Studies, with 2 cited sources on its reference page and 12 indexed studies.
Which is more accessible, Matrixyl or Syn-Coll?
Neither Matrixyl nor Syn-Coll is an FDA-approved drug. Catalog status: Matrixyl, Cosmetic; Syn-Coll, Cosmetic.
Are Matrixyl and Syn-Coll ever combined?
Matrixyl and Syn-Coll appear together in no stack catalogued on PeptideHelper.org, and the interaction engine raises no flag for the pair.
Open the PeptideHelper.org compare tool to add more compounds to this side-by-side and filter by evidence tier interactively.
Loading interactive view…